Mucosal peptic activity during Helicobacter pylori infection in pediatric patients
J Yahav1, G Oderda, A Diver-Haber
1Pediatric Gastroenterology Service, Department of Clinical Microbiology, Tel Hashomer, Israel.
Abstract:
Intramucosal peptic activity may participate in the genesis of acute and chronic superficial gastritis. The proteolytic activity of homogenates of gastric mucosa (antrum and body) and duodenum were measured at pH 2.0 (total peptic activity) after exposure to pH 8.0 (pepsinogen) and the activated pepsinogen (pepsin) was calculated in pediatric patients investigated for the presence of Helicobacter pylori (H pylori), 122 antral, 77 stomach body, and 74 duodenal biopsies were examined in 43 H pylori positive patients, 51 controls, and 28 H pylori negative gastritis patients. Activated pepsinogen was significantly reduced in the stomach of H pylori positive patients only. Pepsinogen values were similar in all the anatomical areas tested in all patients. In 13 H pylori positive patients reinvestigated three months after antibiotic therapy, antral mucosal activated pepsinogen activity increased significantly (mean pretreatment 1.56 (1.0) U/mg protein versus mean post-treatment 2.72 (1.7) U/mg protein) and reached values comparable with controls. The decreased activated pepsinogen activity in association with normal pepsinogen content observed in the antrum of H pylori positive gastritis patients indicate local pepsin inactivation or alternately enhanced removal into the gastric lumen or backflow into the circulation.
Insights
Helicobacter pylori infection reduces activated pepsinogen in pediatric gastritis patients. Antibiotic treatment restored pepsinogen levels, suggesting local pepsin inactivation or enhanced removal in H. pylori positive stomachs.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Peptic activity within the gastric mucosa may contribute to gastritis.
- Helicobacter pylori (H. pylori) infection is a common cause of gastritis.
Purpose of the Study:
- To investigate intramucosal peptic activity in pediatric patients with H. pylori infection.
- To determine the effect of H. pylori on pepsinogen activation in the gastric mucosa.
Main Methods:
- Measurement of total peptic activity and activated pepsinogen in gastric and duodenal biopsies from pediatric patients.
- Comparison of peptic activity in H. pylori positive patients, H. pylori negative gastritis patients, and controls.
- Re-evaluation of peptic activity after antibiotic therapy in H. pylori positive patients.
Main Results:
- Activated pepsinogen was significantly reduced in the stomach of H. pylori positive patients.
- Pepsinogen levels were similar across all tested anatomical areas and patient groups.
- Antibiotic therapy in H. pylori positive patients led to a significant increase in antral mucosal activated pepsinogen.
Conclusions:
- Decreased activated pepsinogen in H. pylori positive gastritis suggests local pepsin inactivation or enhanced clearance.
- Restoration of activated pepsinogen after treatment supports a direct role for H. pylori in altering mucosal peptic activity.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
